We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

RNasin® Ribonuclease Inhibitors: Superior Performance for All of Your RNA Analysis Needs

  • Print
  • Email
  • Download PDF

Abstract

Over 6,000 papers have cited RNasin® Ribonuclease Inhibitors as the source of RNase protection since Promega introduced RNasin® Inhibitors in 1982, making them the most trusted reagents for RNA protection. RNasin® Inhibitors work by binding strongly to RNases, preventing them from degrading vulnerable RNA molecules during manipulation in the laboratory. RNase inhibitors work in a variety of experimental situations and conditions. Reliable RNase inhibitors satisfy three major criteria. This article presents these criteria and shows that RNasin® Ribonuclease Inhibitors fulfill them, ensuring that RNases will not interfere with your RNA analysis work.

Promega Notes 86, 25–27.

Kyle Hooper

Promega Corporation
Publication Date: 2004

Download Article (163 KB)

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.